LISATA THERAP.INC.DL-001 (8NE) — Cash Flow-to-Debt Ratio
LISATA THERAP.INC.DL-001 (8NE) has a Cash Flow-to-Debt Ratio of -1.03x as of December 2025, meaning its operating cash flow of €-3.25 Million could theoretically repay -1% of its total liabilities (€3.14 Million) in one year. See LISATA THERAP.INC.DL-001 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LISATA THERAP.INC.DL-001 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for LISATA THERAP.INC.DL-001 across 5 annual periods. Also explore how fast is LISATA THERAP.INC.DL-001 growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for LISATA THERAP.INC.DL-001 (2021–2025)
Year-by-year debt coverage analysis for LISATA THERAP.INC.DL-001. For market capitalisation and broader financial context, see 8NE market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.07x | €-15.95 Million | €3.14 Million | ▼ -49.0% |
| 2024 | -3.40x | €-19.36 Million | €5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | €-20.03 Million | €6.80 Million | ▲ +6.6% |
| 2022 | -3.15x | €-21.17 Million | €6.71 Million | ▲ +29.0% |
| 2021 | -4.44x | €-22.25 Million | €5.01 Million | — |